Posts Tagged ‘Stroke’

Lung Cancer Foundation Charity 5K Run to Show Support for Boston

Posted: Apr 17, 2013 | Posted by Kassy Perry | No Comments

26-second moment of silence will be observed, runners encouraged to wear blue and yellow

DALLAS, Texas – The 3rd Annual Your Next Step is the Cure 5K walk/run at Reverchon Park on Saturday will honor the victims and heroes of Monday’s Boston Marathon bombing by starting with a 26-second moment of silence – one second for every mile of the marathon.

The Bonnie J. Addario Lung Cancer Foundation (LCF), who is hosting the event to raise funds for lung cancer awareness and research, is also encouraging runners to wear blue and yellow, the colors of the Boston Marathon.

“We are banding together with the running community all over the country this weekend to honor the victims and heroes of the Boston Marathon bombing,” said Bonnie J. Addario, director and founder of the LCF. “Raising awareness for lung cancer is still the goal of our run, but in light of the events this week we felt compelled to show our support.”
READ MORE

California Companies Target Heart Disease, Cancer With More Than 240 Medicines in Development

Posted: May 23, 2011 | Posted by Kassy Perry | No Comments

WASHINGTON–(BUSINESS WIRE)–At a time when cancer and heart disease are the nation’s and the world’s top killers, biopharmaceutical research companies headquartered in California are developing 243 of the 1,186 medicines in development for those dreaded diseases.

The California companies are developing 188 of 887 drugs for more than 20 types of cancer and 55 of 299 medicines for heart disease and stroke.

The cancer statistics are contained in a new report “Medicines in Development for Cancer” published by the Pharmaceutical Research and Manufacturers of America (PhRMA), while the data on heart disease and stroke are from a PhRMA report from early this year.

The cancer report and “Medicines in Development for Heart Disease and Stroke” can be found on the PhRMA website, www.phrma.org.
READ MORE

PhRMA Report: Biopharmaceutical Companies in California Lead the Fight Against Heart Disease, Stroke

Posted: Mar 24, 2011 | Posted by Kassy Perry | No Comments

Washington, D.C. (March 23, 2011) —California’s biopharmaceutical companies are working on nearly one-fifth of new medicines being developed for heart disease and stroke, according to a new report from the Pharmaceutical Research and Manufacturers of America (PhRMA).    

The report shows California companies are developing 55 of 299 new medications for cardiovascular disease.   

“Since 1900, heart disease has topped the list of killer diseases every year but one – 1918 – and stroke is the fourth leading cause of death in America,” PhRMA Deputy Vice President Karl Uhlendorf said today.  “In California, according to the state’s Heart Disease and Stroke Prevention Program, heart disease and stroke are the number one and three causes of death, and a leading cause of disability.  Californians can take heart in knowing that new hope is on the horizon and much of it stems from the innovation of biopharmaceutical companies located throughout the state.”   

New medicines offer the potential for not only improved health, but also lower health care costs.  And, in California, there is a strong need for relief from the burdensome expenses of heart disease.  Average health care spending for cardiovascular patients is nearly six times the average for all patients in the state, according to “Chronic Diseases in California:  Facts and Figures,” a recent report by the California Health Care Foundation. 
READ MORE